Head and Neck: Odontogenic tumor: Ameloblastoma by Angadi, PV






Solid Tumour Section 
Review 
 
Atlas Genet Cytogenet Oncol Haematol. 2011; 15(2)  223 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
OPEN ACCESS JOURNAL AT INIST-CNRS 
Head and Neck: Odontogenic tumor: 
Ameloblastoma 
Punnya V Angadi 
Department of Oral and Maxillofacial Pathology, KLE VK Institute of Dental Sciences and Hospital, 
Nehrunagar, Belguam-590010, Karnataka state, India (PVA) 
 
Published in Atlas Database: May 2010 
Online updated version : http://AtlasGeneticsOncology.org/Tumors/AmeloblastomID5945.html 
DOI: 10.4267/2042/44972 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 





It is considered to be the most common odontogenic 
tumor. It is a tumor of the enamel organ without 
formation of enamel. Robinson has defined it as: 
Unicentric, nonfunctional, intermittent in growth, 
anatomically benign and clinically persistent. The 
importance of this tumor lies in its common 
occurrence, locally invasive behavior which causes 
marked deformity and serious debilitation. They also 
demonstrate increased recurrence rate after surgery. 
Clinics and pathology 
Note 
History: Gorlin identifies Cusack as the first person to 
identify ameloblastoma in 1827. Falkson gave a 
detailed description in 1879. The first histopathologic 
description was given by Wedl (1853) who called the 
tumor cystosarcoma or cystosarcoma adenoids and 
thought that it could have arisen from tooth bud/dental 
lamina. Wagstaffe (1871) gave the first histological 
drawing. Malassez (1885) introduced the term 
"adamantine epithelioma" while Derjinsky (1890) 
introduced the term "adamantinoma". However, this 
term has become obsolete and has to be avoided. Ivy 
and Churchill in 1930 encouraged the use of the term 




Figure 1. Mandibular ameloblastoma presenting as swelling 
causing facial asymmetry. 
Embryonic origin 
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epithelium i.e. from rests of dental lamina. If these rests 
are situated outside the bone in the soft tissues of 
gingiva or alveolar mucosa may give rise to peripheral 
ameloblastoma. Other possible sources of origin 
include gingival surface epithelium and lining of 
odontogenic cysts. 
Epidemiology 
Ameloblastoma although rare, is the most common 
odontogenic tumor accounting for 1% of all tumors in 
head and neck region and around 11% of all 
odontogenic tumors. They usually occur in middle ag
group i.e. 20-40 years with highest incidence noted in 
33 years. They are rare in children (8.7% - 15%). 
Maxillary ameloblastoma and extraosseous 
ameloblastoma occur in a slightly older age group 
while unicystic ameloblastoma (Avg 10.8 years) and 
granular cell ameloblastoma occur in a younger age 
group. It shows equal sex predilection with no specific 
racial predominance. There is conflicting evidence on 
the incidence rates in different races. Although some 
reports claim an increased incidence of ameloblastoma 
in black individuals, a large study identifies Asians as 
the population with greatest number of affected 
patients. 
Ameloblastoma occurs in all areas of jaws, but the 
mandible is the most commonly affected area i.e. more 
than 80% of cases are seen here. Within the mandible, 
the molar angle ramus area is involved three times 
more commonly than are premolar and anterior regions 
combined. In the maxilla, most usually occur in the 
molar area, but may be seen occasionally in the antrior 
region, maxillary sinus and nasal cavity. Based on the 
clinical, radiographic, histopathologic and behavioral 
aspects, four subtypes of ameloblastoma are currently 
identified namely: 
- Classic/solid/multicystic ameloblastoma 
- Unicystic ameloblastoma 
- Peripheral ameloblastoma 
- Desmoplastic ameloblastoma 
Clinics 
Ameloblastoma grow slowly and usually are 
asymptomatic until a swelling is noticed. Most patien s 
thus typically present with a complaint of swelling and 
facial asymmetry. Occasionally, small tumors may be 
identified on routine radiography. As the tumor 
enlarges, it forms a hard swelling and later may cause 
thinning of the cortical bone resulting in an egg shell 
crackling which can be elicited. The slow growth also 
allows for reactive bone formation leading to gross 
enlargement and distortion of the jaw. If the tumor is 
neglected, it may perforate the bone and spread into the 
soft tissues making excision extremely difficult. Pain 
has been reported as an occasional finding which could 
be attributed to secondary infection. Other effects 
include tooth mobility, displacement of teeth, 
resorption of roots, paraesthesia if the inferior alveolar 
canal is involved, failure of eruption of teeth and very 
rarely the ameloblastoma can ulcerate through the 
mucosa. 
Peripheral ameloblastoma usually presents as normal 
colored, smooth surfaced nodules or enlargements but 
occasional tumors may present with erythematous or 
papillary surface. They are slow growing and cause 
little or no bone erosion. Any saucerisation of the 
underlying bone is due to pressure rather than invas on. 
Radiology: Ameloblastoma usually present as a well 
defined, multilocular radiolucency with scalloped 
border typically described as 'honeycomb' or soap 
bubble appearance. However, unicystic ameloblastoma 
typically presents as a unilocular radiolucency 
containing an impacted tooth. They typically infiltrate 
through the medullary bone, therefore the radiographic 
margins are not accurate indicators of the extent of 
involvement. Expansion of buccal and lingual cortical 
plates, displacement and root resorption may also be 
seen. 
Desmoplastic ameloblastoma present with a ill-defined 
radiolucent radiopaque lesion reminiscent of a fibro-
osseous lesion. 
 
Figure 2. A: Ameloblastoma presenting as a multilocular 
radiolucency involving the left mandibular angle and ramus 
region. B: Unicystic ameloblastoma presenting as an unilocular 
radiolucency associated with an impacted mandibular third 
molar. C: Desmoplastic ameloblastoma depicting a ill-defined 
radiolucency with specks of radiopacities in mandibular anterior 
region. 
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Cytology 
Ameloblatoma cytologically usually presents with 
basaloid cells arranged in cells and clusters. These 
basaloid cells have scanty cytoplasm and dense oval 
nucleus. Palisading of these basaloid cells in cell 
clusters is a noticable feature. Additionally, squamous 
cells with abundant cytoplasm and central nucleus can 
also be seen if there is evidence of squamous 
metaplasia. The background is usually eosinophilic and
shows scattered spindle cells and inflammatory cells. 
Pathology 
There are six histopathologic subtypes which have been 
identified for ameloblastoma i.e. follicular, plexiform, 
acanthomatous, basal cell, unicystic and desmoplastic 
ameloblastoma. Mixtures of different patterns are 
commonly observed and the lesions are usually 
classified based on the predominant pattern present. 
Follicular ameloblastoma: These are most readily 
recognizable and common type of ameloblastoma 
histologically. The follicular pattern consist of islands 
of epithelial cells with a central mass of polyhedral 
cells or loosely arranged angular cells resembling 
stellate reticulum, surrounded by well organized single 
layer of cuboidal or tall columnar cells with nuclei 
placed at the opposite pole of basement membrane 
resembling pre-ameloblasts. This peripheral cell layer 
tends to show cytoplasmic vacuolization. Cystic 
formation is often seen in the center of the epithelial 
islands due to degeneration of stellate reticulum like
cells. 
Plexiform ameloblastoma: The tumor epithelium is 
arranged in form of network/tabeculae which is bound 
by a layer of cuboidal or columnar cells and stella 
reticulum like areas are usually minimal. Cyst 
formation occurs but is usually due to stromal 
degeneration rather than cystic change in the 
epithelium. The stroma consists of loose, vascular 
sparsely cellular connective tissue. 
Acanthomatous ameloblastoma: It resembles a 
typical follicular ameloblastoma except it shows 
extensive squamous metaplasia sometimes with keratin 
formation within the epithelial islands. 
Granular cell ameloblastoma: When the central 
stellate reticulum cells show extensive granular cell
transformation i.e. in the form of sheets of large 
eosinophilic granular cells, the tumors are referred to as 
granular cell ameloblastoma. Sometimes this change, 
may be so extensive that the peripheral columnar cells
may also be replaced making the diagnosis difficult 
especially in a small biopsy. Ultrastructurally, it is seen 
that the granules consist of pleomorphic, osmiophilic, 
lysosome like organelles. 
Basal cell ameloblastoma: This variant shows 
predominant basaloid pattern consisting of darkly 
stained cells with minimal cytoplasm and little 
evidence of palisading at the periphery resembling 
those seen in basal cell carcinoma. 
Desmoplastic ameloblastoma: This variant was first 
described in detail by Eversole et al. in 1984 and is 
characterized by extensive stromal collage- 
nization or desmoplasia surrounding compressed 
small/irregular islands of odontogenic epithelium 
making it a distinct entity. Cyst formation is common 
and ameloblast like areas are present only in small foci. 
Calcification in the fibrous stroma and occasional bone 
formation can also be seen. Histochemical evaluation 
of the collagen suggests that the dense stroma is not 
scar tissue but represents active denovo synthesis of 
extracellular matrix proteins. It typically presents 
radiographically as a mixed radiolucency and 
radiopacity mimicking a fibrosseous lesion. In contras  
to typical ameloblastoma, this variant frequents the
maxilla and the anterior region of the jaws. 
Unicystic ameloblastoma: This is considered as an in-
situ or superficially invasive form of ameloblastoma 
and consists of a single cyst lined by ameloblastic 
epithelium. It presents clinically similar to a 
dentigerous cyst and is usually associated with an 
impacted tooth (usually 3rd molars). They are usually 
seen in younger patients with an average age of 
diagnosis being 22 years and generally involve the 
mandible. 
This variant histologically presents as a single cyst 
lined by ameloblastomatous epithelium and is divided 
into several subgroups based on pattern and extent of 
ameloblastomatous proliferation in relation to cyst 
wall. 
Reichart et al. classification modified from Ackermann 
et al.: 
-1. Luminal UA: Cystic lesion lined by epithelium 
which exhibits columnar differentiation and reverse 
polarization of the basal cell layer. The connective 
tissue adjacent to the epithelium often exhibits a 
uniform, thin band like area of hyalinization. 
-1.2. Luminal and intraluminal UA: Is the simple type 
but exhibits one or more nodules projecting into the
lumen. No extension is seen into the surrounding 
connective tissue wall. Occasionally, this form of UA 
can produce an intraluminal plexiform pattern of 
odontogenic epithelium that lacks typical 
ameloblastomatous differentiation and is called as 
unicystic plexiform ameloblastoma. 
-1.2.3. Luminal, intraluminal and intramural UA: Here 
there is occurrence of intramural proliferation of 
ameloblastoma along with subgroup 1.2 features. 
-1.3. Luminal and intramural UA: exhibits a cyst with a 
luminal lining in combination with intramural nodules 
of SMA tissues. The intramural ameloblastoma tissue 
may be seen as an infiltration from the cyst lining or as 
free islands of follicular ameloblastoma. 
Peripheral ameloblastoma: They present 
histologically with follicular or plexiform pattern as 
well as acanthomatous pattern. In most cases, the tumor 
is well separated from the overlying epithelium but 
many are confluent with the overlying mucosa. 
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Figure 3. Figure 3A: Photomicrograph depicting a typical follicular ameloblastoma with islands demonstrating peripheral columnar cells 
exhibiting reversal of polarity and central stellate-reticulum lie cells demonstrating cytic degeneration. Figure 3B and C: 
Photomicrographs depicting acanthomatous variant of ameloblastoma depicting follicles exhibiting extensive squamous metaplasia and 
keratin formation. Figure 3D: Plexiform ameloblastoma with odontogenic epithelium arranged in the form of interlacing trabeculae and 
evidence of stromal degeneration. 
Figure 4. Figure 4A and B: Granular cell ameloblastoma: the central stellate reticulum cells show presence of eosinophilic cells with 
granular cytoplasm. B: demonstrates aplexiform pattern where the peripheral cells have also been replaced by the granular cells. Figure 
4C: Photomicrographs depicting basaloid areas in an ameloblastoma. Figure 4D: Desmoplastic ameloblastoma: Photomicrographs 
depicting compressed epithelial islands surrounded by dense fibrous stroma with evidence of bone formation. 
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Figure 5. Figure 5A and B: Unicystic ameloblastoma: A: Luminal type and B: Plexiform unicystic ameloblastoma. Figure 5C and D: 
Photomicrographs depicting mucous cells in ameloblastoma. 
 
Other rare variants: Clear cell variant which may 
contain clear PAS positive cells are localized in the 
stellate reticulum like areas. 
Papilliferous keratoameloblastoma show occurrence of 
areas of ameloblastoma with keratinisation, tumor 
islands with papilliferrous appearance along with cysti  
areas resembling odontogenic keratocysts. 
Mucous cells can also be demonstrated rarely in 
ameloblastoma. 
Treatment 
The diagnosis has to be confirmed by a biopsy, but 
occasionally in cystic variants it may be made only 
after excision. 
Ameloblastomas, although benign are relentlessly 
infiltrative. Conventional ameloblastoma infiltrates into 
surrounding bone and extends beyond the apparent 
radiographic boundaries seen in plain radiographs. T e 
rate of recurrence reported varies from 20-90%. 
Treatment planning should take into consideration 
tumor size, location, histopathology, and 
clinical/radiographic presentation. 
Treatment with curettage is clearly inadequate and may
leave small islands of tumor within the bone. Marginal 
or en bloc resection is the most widely used form of 
therapy with many surgeons advocating margins of  
 
excision to include 1.5 cm of clinically normal bone. 
Maxillary ameloblastoma are particularly dangerous 
due to bony architecture and they grow upwards to 
involve the sinonasal passages, pterygomandibular 
fossa, orbit, cranium, and brain. Maxillary 
ameloblastomas thus warrant radical surgery as close 
proximity to vital structures makes recurrence 
potentially dangerous in this area. 
Reichart et al. reveal that the overall recurrence rat is 
around 22% and half of them appear 5 years after the 
initial surgical management. Lifelong follow up is 
strongly recommended. Rare malignant transformation 
has also been documented. 
For the luminal and intraluminal variants of unicystic 
ameloblastoma, the tumor is usually confined by the 
fibrous connective tissue wall of the cyst and isusually 
treated with complete enucleation. However, in the 
intramural variants which show invasion into the cyst 
wall is thought represent a typical ameloblastoma and
warrants a more aggressive treatment. Long term 
follow up however remains mandatory. 
Peripheral ameloblastomas are not aggressive clinically 
and can be managed by local excision. A recurrence 
rate of 8% has been reported and a further and wider 
local excision can be curative. 
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Genetics 
Note 
Ameloblastoma usually occur sporadically without any 
apparent genetic predisposition. However, only few 
cases have been reported associated with known 
genetic syndrome i.e. Gorlin Goltz syndrome. 
Cytogenetics 
Note 
There are no specific genetic alteration reported that
indicate an increase risk in development of 
ameloblastoma. 
The various genetic events reported include: 
Loss of tumor suppressor genes L-MYC and PTEN; 
Expression of nrob1-the earliest gene in zebrafish tooth 
development; 
Increased methylation of p16 and p21; 
Aberrant CTNNB1 (beta-catenin gene) and APC 
(adenomatosis polyposis coli gene); 
Increased expression of amelogenin gene. 
Mutations of PTCH1 gene, ameloblastin (ABMN) gene 
and K-RAS gene have been reported. 
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